Can You Get Thyroid Eye Disease With Normal Thyroid Levels?
At a Glance
Yes. Thyroid eye disease can occur even when TSH and free T4 are normal because the immune system can inflame tissues behind the eyes independently of current thyroid function. Eye examination, possible imaging, and ongoing thyroid monitoring are important.
It can be confusing and frightening to experience eye swelling or bulging when your doctor tells you your thyroid blood tests are completely normal. But yes, you can absolutely develop Thyroid Eye Disease (TED) even if your thyroid hormone levels are perfectly normal.
When TED occurs in someone with normal thyroid function (such as normal TSH and free T4 levels), doctors call it euthyroid Thyroid Eye Disease. It can also occur in people with underactive thyroid levels, known as hypothyroid TED.
It is a common misconception that TED is simply a symptom of an overactive thyroid (Graves’ disease). While TED most frequently occurs alongside hyperthyroidism, the eye disease and the thyroid disease are distinct conditions triggered by the same underlying immune system process [1].
How Common is TED Without Hyperthyroidism?
Although hyperthyroidism is the most common presentation, a significant minority of people develop TED without an overactive thyroid. According to a large review of medical studies, approximately 8% of people with TED have normal thyroid levels, and about 10% have low thyroid levels [2]. These estimates vary widely depending on the clinic and population, with some large studies finding that up to 24% of TED patients had normal thyroid levels at diagnosis [3].
Why Does the Eye Disease Happen if the Thyroid is Normal?
TED is an autoimmune disorder. Instead of simply “attacking” and destroying tissue, the body’s immune system produces autoantibodies that mistakenly bind to and activate specific receptors on healthy cells [4][5].
- The Shared Target: One of the main targets is the Thyroid Stimulating Hormone Receptor (TSHR). These receptors are found on the thyroid gland, but they are also located on the cells and tissues behind your eyes, known as orbital fibroblasts [5][1]. Other receptors, such as the IGF-1 receptor, are also involved in this complex immune response [6].
- The Eye Inflammation: When these autoantibodies bind to the receptors behind the eyes, they trigger an inflammatory response [4]. The cells are stimulated to produce inflammatory mediators and a gel-like fluid called hyaluronan, which causes the fat and muscles around the eye to swell [7][8]. This swelling pushes the eye forward, causing bulging (proptosis) and restricted eye movement [9].
Because the eyes and the thyroid gland share these targets, the immune system can affect both [1]. However, the activity of the eye disease does not perfectly track your thyroid hormone levels. Your thyroid can be functioning normally at this moment, while the autoantibodies actively stimulate the tissues around your eyes [10].
Patterns That May Be Seen in Euthyroid TED
Research indicates that when TED occurs in people with normal or low thyroid levels, it may show slightly different patterns:
- Asymmetrical Symptoms: It is more common for euthyroid TED to be unilateral—affecting mostly one eye, or affecting one eye much more severely than the other [3][11]. However, unilateral eye bulging is not automatically TED. An ophthalmologist must evaluate you and likely perform orbital imaging (such as a CT or MRI) to rule out other potential causes, such as an infection or tumor.
- Disease Severity: While some specialized clinic studies found cases with normal or low thyroid levels to be milder on average, moderate and severe cases certainly still occur [3][11]. Your thyroid status does not reliably predict how severe your eye symptoms will be or your overall risk to vision.
- Antibody Tests: Routine blood tests measuring thyroid autoantibodies (such as TRAb or TSI) might sometimes come back “negative” in euthyroid patients. While specialized, highly sensitive tests can sometimes detect the specific antibodies [12], an antibody test by itself does not prove or exclude TED. Diagnosis requires a clinical eye examination and often imaging.
What This Means for Your Care
If you are diagnosed with TED but have normal thyroid levels, your care will require a coordinated team:
- Eye Care and Urgent Symptoms: Treatment for the eye disease depends on whether the disease is “active” (ongoing inflammation) or “inactive” (stable, though physical changes may linger). Mild disease may only require lubricating drops and close observation, while more severe cases may require specialized systemic medications or surgery. Seek immediate medical attention if you experience reduced or blurred vision, faded color vision, new or severe eye pain, rapidly worsening bulging, or an inability to close your eyelids. These can be signs of sight-threatening complications like optic nerve compression or severe corneal damage.
- Thyroid Monitoring: Maintaining stable, normal thyroid hormone levels is a crucial part of TED care. You should have your thyroid monitored regularly by an endocrinologist, as people with euthyroid TED can develop an overactive or underactive thyroid over time [2].
- Smoking Cessation: Smoking and secondhand smoke strongly worsen TED. Quitting smoking is one of the most important lifestyle changes you can make to protect your eyes.
Common questions in this guide
Can thyroid eye disease occur when my TSH and free T4 are normal?
How often does TED occur without an overactive thyroid?
Why can my eyes be affected if my thyroid blood tests are normal?
Can normal thyroid tests or negative antibody results rule out TED?
How is thyroid eye disease treated when thyroid levels are normal?
Should I keep checking my thyroid after being diagnosed with euthyroid TED?
Which thyroid eye disease symptoms need urgent medical attention?
Questions For You
Answer a question to get research tailored to you. Your answers are private.
Related questions
Show more
Get notified when new evidence is published on thyrotoxic exophthalmos.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my one-sided symptoms, do I need orbital imaging (like an MRI or CT scan) to confirm TED and rule out other causes?
- 2.Has my vision, color vision, visual field, and optic nerve been thoroughly checked?
- 3.Are my current eye symptoms considered 'active' (inflamed) or 'inactive', and what are my best options for managing them?
- 4.How frequently should we monitor my thyroid hormone levels moving forward, in case they begin to change?
- 5.What specific symptoms should prompt me to call you or go to urgent care immediately?
References
References (12)
- 1
Insulin-like Growth Factor-I Receptor and Thyroid-Associated Ophthalmopathy.
Smith TJ, Janssen JAMJL
Endocrine reviews 2019; (40(1)):236-267 doi:10.1210/er.2018-00066.
PMID: 30215690 - 2
Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: a systematic review of the literature.
Muñoz-Ortiz J, Sierra-Cote MC, Zapata-Bravo E, et al.
Systematic reviews 2020; (9(1)):201 doi:10.1186/s13643-020-01459-7.
PMID: 32873324 - 3
Clinical phenotypes of euthyroid, hyperthyroid, and hypothyroid thyroid-associated ophthalmopathy.
Yang M, Wang Y, Du B, He W
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 2023; (261(7)):1995-2002 doi:10.1007/s00417-023-05998-2.
PMID: 36806995 - 4
Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management.
Wiersinga WM, Eckstein AK, Žarković M
The lancet. Diabetes & endocrinology 2025; (13(7)):600-614 doi:10.1016/S2213-8587(25)00066-X.
PMID: 40324443 - 5
Is There Evidence for IGF1R-Stimulating Abs in Graves' Orbitopathy Pathogenesis?
Krieger CC, Neumann S, Gershengorn MC
International journal of molecular sciences 2020; (21(18)) doi:10.3390/ijms21186561.
PMID: 32911689 - 6
Targeting TSH and IGF-1 Receptors to Treat Thyroid Eye Disease.
Neumann S, Krieger CC, Gershengorn MC
European thyroid journal 2020; (9(Suppl 1)):59-65 doi:10.1159/000511538.
PMID: 33511086 - 7
Pathophysiology of thyroid-associated orbitopathy.
Lee ACH, Kahaly GJ
Best practice & research. Clinical endocrinology & metabolism 2023; (37(2)):101620 doi:10.1016/j.beem.2022.101620.
PMID: 35181241 - 8
Thyroid eye disease: From pathogenesis to targeted therapies.
Yoon JS, Kikkawa DO
Taiwan journal of ophthalmology 2022; (12(1)):3-11 doi:10.4103/tjo.tjo_51_21.
PMID: 35399971 - 9
Immunological Aspects of Graves' Ophthalmopathy.
Łacheta D, Miśkiewicz P, Głuszko A, et al.
BioMed research international 2019; (2019()):7453260 doi:10.1155/2019/7453260.
PMID: 31781640 - 10
MRI-based evaluation of orbital structures in relation to thyroid function in thyroid eye disease.
Barlas T, Yalcin MM, Temel E, et al.
Endocrine 2026; (91(1)).
PMID: 42067739 - 11
Prevalence, Phenotype, and Psychosocial Well-Being in Euthyroid/Hypothyroid Thyroid-Associated Orbitopathy.
Ponto KA, Binder H, Diana T, et al.
Thyroid : official journal of the American Thyroid Association 2015; (25(8)):942-8 doi:10.1089/thy.2015.0031.
PMID: 26244413 - 12
Rapid and sensitive bioassay for thyroid-stimulating immunoglobulin detection in thyrotropin-binding inhibitory immunoglobulin-negative euthyroid Graves' orbitopathy.
Hötte GJ, Van der Burg M, Dik WA, et al.
European journal of endocrinology 2025; (193(5)):675-684 doi:10.1093/ejendo/lvaf210.
PMID: 41074265
This page explains how thyroid eye disease can occur with normal thyroid tests for informational purposes only and does not constitute medical advice. An ophthalmologist and endocrinologist can evaluate your symptoms and recommend appropriate care.